Disease Awareness and Prescription Drug Promotion on Television

OMB 0910-0874

OMB 0910-0874

This research concerns disease awareness and prescription drug promotion communications on television. When pharmaceutical companies market a new drug, they often also release disease awareness communications about the medical condition the new drug is intended to treat. FDA is interested in whether and to what extent this practice may result in consumers confusing or otherwise misinterpreting the different information and claims presented in disease awareness communications and prescription drug promotion. We propose two studies designed to provide insights on this topic.

The latest form for Disease Awareness and Prescription Drug Promotion on Television expires 2021-08-31 and can be found here.

OMB Details

Study 1 - Pretest Screener

Federal Enterprise Architecture: Health - Consumer Health and Safety


© 2021 OMB.report | Privacy Policy